Please assess the completion status of the following clinical trial:

Trial Title: Treating Childhood Apraxia of Speech

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Native English speakers who hear English as the dominant language in their home setting.~* Must pass a hearing screening.~* Score at or better than -2 standard deviations from the mean on the Matrix Reasoning Task of the Wechsler Abbreviated Scale of Intelligence - 2nd Edition (WASI-2; t-score ≥ 30), Peabody Picture Vocabulary Test - 4th Edition (PPVT-4; standard score ≥ 70), and the Following Directions subtest of the Clinical Evaluation of Language Fundamentals - 5th Edition (CELF-5; scaled score ≥ 3).~* Goldman-Fristoe Test of Articulation - 3rd Edition (GFTA-3) percentile ≤ 5th).~* A diagnosis of CAS will be verified based on a polysyllable picture naming task, diadochokinetic task (puh-tuh-kuh), and syllable repetition task.~Exclusion Criteria:~* Parent report or direct evaluation reveals oral-facial structural abnormalities (e.g., cleft palate).~* Parental report of neurobehavioral disorders (e.g., autism spectrum disorders, ADHD, obsessive-compulsive disorder), or vision problems that are corrected with glasses/contacts.~* Fail a hearing screening, or failure to meet criteria listed above as Inclusionary

- Gender: ALL
- Minimum Age: 9 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Biofeedback, Massed->Distributed (Type: EXPERIMENTAL): Sequenced biofeedback Mass Practice--\> Distributed Scheduling
- No Biofeedback, Distributed (Type: ACTIVE_COMPARATOR): Speech Motor Chaining with no biofeedback. 2 sessions/wk for 10 weeks
- Biofeedback, Distributed (Type: EXPERIMENTAL): Sequenced biofeedback, 2 sessions/wk for 10 weeks
- No Biofeedback, Massed-> Distributed (Type: EXPERIMENTAL): Speech Motor Chaining with no biofeedback. Mass Practice--\> Distributed Scheduling

Based on this trial design, predict the completion outcome and termination type (if applicable).